Ирландия - английский - HPRA (Health Products Regulatory Authority)

bristol-myers squibb (holdings) limited - kanamycin attapulgite pectin bismuth camphocarbonate -

ЮАР - английский - South African Health Products Regulatory Authority (SAHPRA)

opus -

ЮАР - английский - South African Health Products Regulatory Authority (SAHPRA)

opus -

Филиппины - английский - FDA (Food And Drug Administration)

pan-ject pharmaceuticals corp.; distributor: pan-ject pharmaceuticals corp. - tranexamic acid - solution for injection (iv) - 100mg/ml (500mg/5ml)

Канада - английский - Health Canada

sandoz canada incorporated - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes

Канада - английский - Health Canada

hikma canada limited - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes

Канада - английский - Health Canada

sterimax inc - acetylcysteine - solution - 200mg - acetylcysteine 200mg

Израиль - английский - Ministry of Health

rafa laboratories ltd - pralatrexate - solution for injection - pralatrexate 20 mg/ml - pralatrexate - pralatrexate - for the treatment of patients with relapsed or refractory peripheral t-cell lymphoma (ptcl).

Австралия - английский - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - pralatrexate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - folotyn is indicated for the treatment of adult patients with peripheral t-cell lymphoma (nodal, extranodal, and leukaemic/disseminated) who have progressed after at least one prior therapy.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - pralatrexate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - folotyn is indicated for the treatment of adult patients with peripheral t-cell lymphoma (nodal, extranodal, and leukaemic/disseminated) who have progressed after at least one prior therapy.